Adam Friedman, MD, FAAD
Disclosures: Consultant-Aveeno; Dermira; Janssen; La Roche Posay; Microcures; Novartis; and Zylo|Speakers Bureau-AbbVie; Dermira; and Regeneron|Stock Shareholder-Intraderm; Microcures; and Zylo
No Bio Available.